Boditech Med Inc. (KOSDAQ:206640)
12,880
+180 (1.42%)
Jan 20, 2026, 9:40 AM KST
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 276.65 billion as of January 16, 2026. Its market cap has decreased by -23.89% in one year.
Market Cap
276.65B
Enterprise Value
272.73B
Revenue
151.75B
Ranking
n/a
PE Ratio
10.16
Stock Price
12,880.00
Market Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 276.65B, an increase of 882.69%. That is a compound annual growth rate of 24.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 276.65B | -3.20% |
| Dec 30, 2025 | 285.80B | -22.50% |
| Dec 30, 2024 | 368.76B | -18.12% |
| Dec 28, 2023 | 450.36B | 100.01% |
| Dec 29, 2022 | 225.17B | -41.09% |
| Dec 30, 2021 | 382.21B | -29.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |